Phenylbuttersaeure-Lost
Brand names,
Phenylbuttersaeure-Lost
Analogs
Phenylbuttersaeure-Lost
Brand Names Mixture
Phenylbuttersaeure-Lost
Chemical_Formula
C14H19Cl2NO2
Phenylbuttersaeure-Lost
RX_link
http://www.rxlist.com/cgi/generic2/leukeran.htm
Phenylbuttersaeure-Lost
fda sheet
Phenylbuttersaeure-Lost
msds (material safety sheet)
Phenylbuttersaeure-Lost
Synthesis Reference
No information avaliable
Phenylbuttersaeure-Lost
Molecular Weight
304.212 g/mol
Phenylbuttersaeure-Lost
Melting Point
65 oC
Phenylbuttersaeure-Lost
H2O Solubility
1.24E+004 mg/L
Phenylbuttersaeure-Lost
State
Solid
Phenylbuttersaeure-Lost
LogP
3.25
Phenylbuttersaeure-Lost
Dosage Forms
Tablet
Phenylbuttersaeure-Lost
Indication
For treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's disease
Phenylbuttersaeure-Lost
Pharmacology
Chlorambucil is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death.
Phenylbuttersaeure-Lost
Absorption
No information avaliable
Phenylbuttersaeure-Lost
side effects and Toxicity
No information avaliable
Phenylbuttersaeure-Lost
Patient Information
No information avaliable
Phenylbuttersaeure-Lost
Organisms Affected
Humans and other mammals